PI Industries Unveils New Logo, Reflecting its Evolution into a Global Life Sciences Company
Pioneering Innovation in Life Sciences from India to the WorldMUMBAI, India, Feb. 24, 2026 /PRNewswire/ -- PI Industries Ltd (PI)...
Read moreDetails
Health & Fitness
Kyndryl and University of Liverpool to Spearhead Health Innovation with Agentic AI
Collaboration combines Kyndryl's AI Innovation Lab and Kyndryl Consult AI expertise with the University of Liverpool's Civic Health Innovation Labs...
Read moreDetailsdisAMR Acquires AMR Insights to Build the Leading Global Hub for Antimicrobial Resistance (AMR) Innovation, Investment, and Policy Alignment
NEW YORK, Feb. 24, 2026 /PRNewswire/ -- disAMR, a new company formed by partners who built Brammer Bio and have worked...
Read moreDetailsBPC Instruments receives two repeat orders from Denmark within biogas applications
LUND, Sweden, Feb. 24, 2026 /PRNewswire/ -- BPC Instruments AB (publ) has received two repeat orders from Denmark within biogas...
Read moreDetails
etherna’s intratumoral mRNA/LNP platform advances to clinical testing in nonmelanoma skin cancer led by Almirall
NIEL, Belgium, Feb. 24, 2026 /PRNewswire/ -- etherna, a leading provider of cutting-edge mRNA and lipid nanoparticle (LNP) technology across the...
Read moreDetailsSciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China
HANGZHOU, China, Feb. 24, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences") today announced a strategic commercialization collaboration...
Read moreDetailsLeading the Healthcare Dialogue at World Health Expo
DUBAI, UAE, Feb. 24, 2026 /PRNewswire/ -- This February, as the global healthcare community convened in Dubai for World Health Expo,...
Read moreDetailsAcromegaly Market Poised for Significant Expansion During the Forecast Period (2026-2036) as New Treatment Options Emerge | DelveInsight
The dynamics of the acromegaly market are anticipated to change due to extensive R&D, the entry of novel therapies such...
Read moreDetailsTyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium
CARLSBAD, Calif., Feb. 23, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation...
Read moreDetailsHaemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
BOSTON, Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions...
Read moreDetails